Molecular Therapy: Oncology
Издатель: Elsevier · ISSN 2950-3299 · 83 статей
- Emerging cell therapies for gastrointestinal cancers: Advances and future perspectives
- Overcoming translational and manufacturing barriers of CAR-T cell therapy in the Brazilian landscape
- ATMPs in oncology: A comprehensive review of CAR-T and CIK cell therapies within the European regulatory framework
- Preclinical evaluation of triple-mutated oncolytic herpes virus expressing fusion-type interleukin 12 for malignant melanoma
- Engineering “off-the-shelf” TCR-T cells: A transient mRNA platform for balanced alloreactivity and functionality
- FOXM1 drives cisplatin resistance in ovarian cancer through STIM1-mediated SOCE and STAT1 activation
- A novel spliceosome inhibitor triggers anti-tumor CD4+ and CD8+ T cell responses in murine models of pediatric-relevant cancer
- Epitope selection overcomes antigen shedding to enable effective CAR-M therapy in solid tumors
- Phase 1 evaluation of APN401, an autologous CBL-B-silenced PBMC therapy, in advanced solid tumors
- Targeting Hippo-MAPK crosstalk in schwannoma: Overcoming resistance with dual inhibition
- Interleukin-21 expressing oncolytic vaccinia virus elicits systemic anti-tumor immune response and synergizes with immunotherapies
- CD4+ T cells are required for tumor antigen-expressing oHSV glioma therapeutic effect and antigen-specific antibody production
- PD-L1 transmembrane domain substitution overcomes CAR-T exhaustion driven by tonic signaling
- MRPL47 as a mitochondrial biomarker for early detection and therapeutic response in ovarian cancer
- ICAM-1 as a biomarker of efficacy for oncolytic coxsackievirus A21 in patient-derived Ewing sarcoma models
- Therapeutic potential of oncolytic Zika virus in NF1-associated tumors
- PM54 induces transcriptional collapse across cell-derived and patient-derived cancer models
- An asymmetric split-costimulatory MSLN.BBz/NKG2D.28 dual CAR-T design enhances activity against antigenically heterogeneous pancreatic cancer
- Continuous in situ production of CAR T cells from in vivo-transduced HSCs is safe and delays growth of mouse HER2high tumors
- CARM1-expressing ovarian cancers are selectively sensitive to HSP70 inhibition
- The RNA-binding protein RPS3 accelerates cell cycling via the Wnt/β-catenin signaling pathway in pancreatic cancer
- CD26 cytoplasmic tail serves as a potential costimulatory domain in CAR-T cells
- First-in-human anti-Trop2 CAR-T cell therapy in refractory INI-1/BRM-deficient sinonasal carcinoma: A case report